Compare TCBIO & BRKRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
Current Price
| Metric | TCBIO | BRKRP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 1818 | 11396 |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | TCBIO | BRKRP |
|---|---|---|
| Price | $22.72 | $292.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 42.4K | 869.0 |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.11 | $256.35 |
| 52 Week High | $22.95 | $419.83 |
| Indicator | TCBIO | BRKRP |
|---|---|---|
| Relative Strength Index (RSI) | 63.76 | 35.82 |
| Support Level | $20.11 | $289.57 |
| Resistance Level | N/A | $322.28 |
| Average True Range (ATR) | 0.39 | 2.43 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 60.24 | 5.02 |
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.